Anixa Biosciences Stock Price on October 7, 2024
| ANIX Stock | USD 3.32 0.10 3.11% |
Below is the normalized historical share price chart for Anixa Biosciences extending back to November 05, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Anixa Biosciences stands at 3.32, as last reported on the 27th of November, with the highest price reaching 3.44 and the lowest price hitting 3.28 during the day.
If you're considering investing in Anixa Stock, it is important to understand the factors that can impact its price. At this stage we consider Anixa Stock to be risky. Anixa Biosciences secures Sharpe Ratio (or Efficiency) of 0.0199, which signifies that the company had a 0.0199% return per unit of risk over the last 3 months. We have found thirty technical indicators for Anixa Biosciences, which you can use to evaluate the volatility of the firm. Please confirm Anixa Biosciences' Mean Deviation of 2.65, downside deviation of 3.35, and Risk Adjusted Performance of 0.0183 to double-check if the risk estimate we provide is consistent with the expected return of 0.0847%.
At this time, Anixa Biosciences' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 37.4 M in 2024, whereas Common Stock Total Equity is likely to drop slightly above 264.2 K in 2024. . At this time, Anixa Biosciences' Price To Sales Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.35 in 2024, whereas Price Earnings Ratio is likely to drop (9.43) in 2024. Anixa Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 1st of January 1987 | 200 Day MA 3.1143 | 50 Day MA 3.251 | Beta 0.85 |
Anixa |
Sharpe Ratio = 0.0199
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | ANIX | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.26 actual daily | 37 63% of assets are more volatile |
Expected Return
| 0.08 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Anixa Biosciences is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Anixa Biosciences by adding it to a well-diversified portfolio.
Price Book 4.7594 | Enterprise Value Ebitda (8.76) | Price Sales 481.5351 | Shares Float 30.6 M | Wall Street Target Price 8.5 |
Anixa Biosciences Main Headline on 7th of October 2024
Anixa Biosciences Appoints Suyasha Gupta as Senior Director ... by finance.yahoo.com
Anixa Biosciences, Inc. , a biotechnology company focused on the treatment and prevention of cancer, today announced the appointment of Suyasha Gupta as Senior Director of Clinical Development. In this role, Ms. Gupta will work closely with Dr. Pamela Garzone, Chief Development Officer, to oversee the Companys ongoing Phase 1 breast cancer vaccine and Phase 1 ovarian cancer CAR-T therapy clinical trials, as well as the upcoming Phase 2 breast cancer vacc
Anixa Biosciences Valuation on October 7, 2024
It is possible to determine the worth of Anixa Biosciences on a given historical date. On October 7, 2024 Anixa was worth 3.13 at the beginning of the trading date compared to the closed value of 3.13. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Anixa Biosciences stock. Still, in general, we apply an absolute valuation method to find Anixa Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Anixa Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Anixa Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 3.17 | 3.17 | 3.11 | 3.15 | 28,356 | |
10/07/2024 | 3.13 | 3.20 | 3.13 | 3.13 | 23,369 |
| 3.13 | 3.19 | 3.04 | 3.08 | 35,584 |
| Backtest Anixa Biosciences | | | Anixa Biosciences History | | | Anixa Biosciences Valuation | Previous | Next |
Anixa Biosciences Trading Date Momentum on October 7, 2024
| On October 08 2024 Anixa Biosciences was traded for 3.08 at the closing time. The top price for the day was 3.19 and the lowest listed price was 3.04 . The trading volume for the day was 35.6 K. The trading history from October 8, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.60% . The overall trading delta against the current closing price is 0.64% . |
Anixa Biosciences Fundamentals Correlations and Trends
By evaluating Anixa Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Anixa Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Anixa financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Anixa Biosciences Stock history
Anixa Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Anixa is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Anixa Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Anixa Biosciences stock prices may prove useful in developing a viable investing in Anixa Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 35.6 M | 37.4 M | |
| Net Loss | -12.2 M | -12.8 M |
Anixa Biosciences Quarterly Net Working Capital |
|
Anixa Biosciences Stock Technical Analysis
Anixa Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Anixa Biosciences Period Price Range
Low | November 27, 2024
| High |
0.00 | 0.00 |
Anixa Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Anixa Biosciences November 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Anixa Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Anixa Biosciences shares will generate the highest return on investment. By undertsting and applying Anixa Biosciences stock market strength indicators, traders can identify Anixa Biosciences entry and exit signals to maximize returns
Anixa Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Anixa Biosciences' price direction in advance. Along with the technical and fundamental analysis of Anixa Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Anixa to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0183 | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.62) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.0529 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Anixa Stock Analysis
When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.